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Abstract
Background
People of Sub Saharan Africa (SSA) and South Asians(SA) ethnic minorities living in
Europe have higher risk of stroke than native Europeans(EU). Study objective is to provide
an assessment of gender specific absolute differences in office systolic(SBP) and diastolic
(DBP) blood pressure(BP) levels between SSA, SA, and EU.
Methods and Findings
We performed a systematic review and meta-analysis of observational studies conducted in
Europe that examined BP in non-selected adult SSA, SA and EU subjects. Medline,
PubMed, Embase, Web of Science, and Scopus were searched from their inception through
January 31st 2015, for relevant articles. Outcome measures were mean SBP and DBP dif-
ferences between minorities and EU, using a random effects model and tested for heteroge-
neity. Twenty-one studies involving 9,070 SSA, 18,421 SA, and 130,380 EU were included.
Compared with EU, SSA had higher values of both SBP (3.38 mmHg, 95% CI 1.28 to 5.48
mmHg; and 6.00 mmHg, 95% CI 2.22 to 9.78 in men and women respectively) and DBP
(3.29 mmHg, 95% CI 1.80 to 4.78; 5.35 mmHg, 95% CI 3.04 to 7.66). SA had lower SBP
than EU(-4.57 mmHg, 95% CI -6.20 to -2.93; -2.97 mmHg, 95% CI -5.45 to -0.49) but similar
DBP values. Meta-analysis by subgroup showed that SA originating from countries where
Islam is the main religion had lower SBP and DBP values than EU. In multivariate meta-
regression analyses, SBP difference between minorities and EU populations, was influ-
enced by panethnicity and diabetes prevalence.
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Conclusions
1) The higher BP in SSA is maintained over decades, suggesting limited efficacy of preven-
tion strategies in such group in Europe;2) The lower BP in Muslim populations suggests that
yet untapped lifestyle and behavioral habits may reveal advantages towards the develop-
ment of hypertension;3) The additive effect of diabetes, emphasizes the need of new strate-
gies for the control of hypertension in groups at high prevalence of diabetes.
Introduction
The high rate of influx and settlement of migrant populations into Europe is changing the
dynamics of regional population growth, and may pose important challenges for public health
and clinical care [1]. Both subjects originating from Sub Saharan Africa (SSA) [2] and South
Asia (SA) [3] were found to have higher risk of stroke [4,5] and end-stage renal failure[5,6]
than native Europeans(EU). SA subjects living in Europe also have elevated risk of coronary
heart disease [5,7,8]. Understanding the reasons behind the excess of cardiovascular (CV) risks
is crucial for addressing ethnic inequalities in health also because the ageing of migrant popula-
tions carries the risk of overburdening the majority of the healthcare systems in the European
Union that offer free of charge access to emergency medical care [9]. In the USA, studies on
ethnic variation in health risk reveal a major confounding effect by socio-economic status [10].
In Europe, ethnic differences in CV events persist after adjusting for income differences, sug-
gesting that other variables might play a role [11]. Detection and control of risk factors such as
hypertension and diabetes, identification of potential drivers predisposing ethnic minority
groups to CV disease, and recognizing at risk sub-populations may be crucial to build effective
prevention strategies [12,13]. Currently only four European Union member states (Nether-
lands, France, Portugal and Spain) cover the costs of long-term medical care for chronic disease
in undocumented migrants [1,14]. However, previous reviews collecting UK based studies data
were not pooled making it difficult to estimate actual differences between the groups.
As a major CV risk factor, hypertension needs to be carefully managed. An early review
showed higher blood pressure(BP) levels in SSA than in EU [15]. Reductions in salt intake was
reported to produce greater BP decreases in African-Americans [16,17] and a national strategy
to reduce population levels of salt intake was finally introduced in the United Kingdom (UK)
in 2003 [18,19].
Regarding the SA population, a systematic review[20] showed that BP levels are lower in
Bangladeshis followed by Pakistanis and Indians, than in EU. The close relationship between
diabetes and obesity has more recently driven the attention also to body weight reduction [21].
However, the potential contribution of other associated risk factors and behaviours was not
previously investigated
The goal of this study was to perform a systematic review and meta-analysis of studies com-
paring BP levels of EU with those of SSA and SA with the aims of 1) estimating the absolute BP
differences among panethnic subgroups, 2) assessing whether such differences are affected by
the year of the study; and finally 3) assessing the potential contribution of other associated risk
factors and behaviours. The term panethnicity usually refers to a collectivity consisting of dis-
tinct ethnic groups and cultures that experience themselves as having something in common
[22] and was adopted to stress the limitations of grouping together, and collective labelling SSA
and SA subjects of various separate ethnicities.
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Study; CSS, Cross Sectional Survey; CS, Cohort
Study; FB, Factory Based; GPL, General Practices
List; HC, Health Centre; PL, Population List; OS,
Office staff; IC, Immigrant centres; NL, The
Netherlands; NO, Norway; I, Italy; CB, Country of
Birth; NR, Not Reported; N, Name; SR, Self-
Reported; RZ, Random Zero manometer; A,
Automated sphygmomanometer; M, Men; W,
Women.
Materials and Methods
Literature review and data sources
Searches of MEDLINE, PubMed, EMBASE, Web of Science, and Scopus databases, from their
inception to January 31st, 2015 without language restriction, were undertaken. The search
terms ‘Asians’, ‘South Asians’, ‘Caribbean and Asian’, ‘Indians’, ‘East Indian’, ‘Pakistanis’, ‘Ban-
gladeshis’, ‘Africans’, ‘African Caribbean’, ‘West Africans’, ‘Black’, ‘racial stock’, and ‘ethnic
minority groups’ were combined with blood pressure, hypertension and Europe. Additionally,
we hand-searched reference lists, screened citations of articles of interest and approached an
international panel of experts in the field to identify additional published studies. Studies that
were not published as full reports, such as conference abstracts and letters to the editor, were
excluded.
Inclusion criteria
There were no language restrictions. Studies were eligible for inclusion if they 1) compared BP
levels in subjects originating from SSA or SA countries and living in Europe with those of EU;
2) reported office systolic(SBP) and diastolic BP(DBP) values with standard deviation, stan-
dard error, or 95% confidence intervals(CI); 3) enrolled adult individuals (age16 years) at
random from the general population.
Data abstraction and assessment of study quality
Data were extracted from each paper with customised data extraction forms. Attempts were
made to retrieve missing data after contacting the corresponding author. Missing variance
measures were imputed using published formulas [23]. Three reviewers independently assessed
the risk of bias of each of the included studies and discussed their assessments to achieve con-
sensus. A score for quality, modified from the Newcastle-Ottawa scale, was used to assess
appropriateness of research design, recruitment strategy, response rate, representativeness of
sample, objectivity/reliability of outcome determination, power calculation provided, and
appropriate statistical analyses. Score disagreements were resolved by consensus and a final
agreed-upon rating was assigned to each study. We used the PRISMA (Preferred Reporting
Items for Systematic reviews and Meta-Analyses) statement for reporting systematic reviews
and meta-analyses as a guide for this study (S1 Text) [24], including the preparation of a proto-
col and analysis plan (S2 Text).
Statistical analysis
Descriptive data are reported as means with 95% CI or median and range. Main outcome mea-
sures were the mean differences in SBP and DBP between SSA, SA, and EU. Data were pooled
using a random-effect model and the I2 statistics was used to assess heterogeneity, where
I2>50% was considered as evidence of significant heterogeneity [25]. In addition, we used Gal-
braith’s radial plots to visualize heterogeneity and the contribution of each study to the overall
estimate[26]. Pre-specified subgroups included panethnic groups (SSA, SA, and EU) and gen-
der. A generalised Q-statistics was used to evaluate differences among subgroups [27]. The
potential unit-of-analysis issue related to multiple comparisons from a single study population
(e.g. multi-ethnic studies where the EU control group was used more than once) was addressed
by splitting the variance of the EU controls across the available comparisons [23].
Sources of heterogeneity were further investigated by random effect meta-regression analy-
ses [25]. Potential effect modifiers, besides panethnicity and gender, included the study year
and the differences in diabetes prevalence, age, body mass index(BMI), and smoking
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prevalence. Differences were calculated by subtracting the reported values of minority groups
from those of EU populations. Studies including SA subjects were also categorized according to
the country of origin and the main religion in the country of origin (Islam for Pakistan and
Bangladesh; other for India, Sri Lanka, and Suriname)[28].
Model fit was assessed using the proportion of the between-study variance explained by the
covariates (adjusted R2), along with a significance test for each covariate. The proportion of
between-study variance explained by the covariates was calculated by comparing the residual
between-study variance in the final model(τ2) with its value in a model without covariates (t20).
The adjusted R2, the relative reduction in the between-study variance, was calculated according
to the formula: R2adj ¼
ðt2
0
t2Þ
t2
0
[29]. To control for false-positive findings (type I error), when
performing meta-regression with multiple covariates, we used the model F value and its statisti-
cal significance to assess whether there was evidence for an association of any of the covariates
with the outcome, and a test based on random permutations to calculate multiplicity adjusted
P value [29,30]. Publication bias was assessed by visual inspection of the funnel and regression
test. To assess the impact of potentially “missing” studies on pooled estimates, sensitivity analy-
ses were conducted using the Duval and Tweedie nonparametric “trim and fill” method using
both the L0 and R0 estimator [31,32].
Two-sided tests for overall effects were considered significant at p0.05. Statistical analyses
were performed using STATA 13 (StataCorp LP,College Station,Texas,USA) and R(R Founda-
tion for Statistical Computing,Vienna,Austria).
Results
Characteristics of the included studies
A total of 23 studies met inclusion criteria and were included in our meta-analysis (Fig 1).
The main characteristics of included studies are reported in Table 1. Data on SSA were pro-
vided in fifteen studies [33–47] (Table 2), nineteen studies providing data on SA
[34,36,37,39,41,44–57](Table 3). Some of these studies involved several groups of individuals,
so that a total of 17 and 26 comparison groups were available for analysis for SSA and SA
respectively. Sample size ranged from 115 to 59,952 participants (median, 1,578), with a total
of 9,070 SSA (3,894 men and 5,176 women), 18,421 SA(10,021 men and 8,400 women), and
130,380 EU (67,768 men and 65,612 women). The percentage of men ranged from 32% to
100% for SSA (median, 44%), from 41% to 100% for SA (median, 51%), and from 44% to 100%
for EU (median, 51%).
Panethnicity and blood pressure
SSA had higher BP values than EU subjects for both SBP (3.38 mmHg; 95% CI 1.28 to 5.48 in
men; 6.00 mmHg, 95% CI 2.22 to 9.78 mmHg in women) (Fig 2) and DBP (3.29 mmHg, 95%
CI 1.80 to 4.78 mmHg in men; 5.35 mmHg, 95% CI 3.04 to 7.66 in women) (Fig 3).
On the contrary, SA had SBP values lower than EU (-4.57 mmHg, 95% CI -6.20 to -2.93
mmHg in men; -2.97 mmHg, 95% CI -5.45 to -0.49 mmHg in women) (Fig 2). They also
tended to have lower, albeit not significantly, DBP values (-0.56 mmHg, 95% CI -1.71 to 0.58
in men; -0.13 mmHg, 95% CI -1.12 to 0.87 in women) (Fig 3). Effect sizes of individual studies
on South Asians are reported in S1 Fig (for systolic BP) and in S2 Fig (for diastolic BP). Effect
sizes of individual studies on Sub-Saharan Africans are reported in S3 Fig (for systolic BP) and
in S4 Fig (for diastolic BP).
In these analyses, however, we found evidence of statistical heterogeneity among studies.
The I-squared statistic ranged between 90.3% and 96.1% for SBP, and between 90.7% and
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96.2% for DBP. Notably, gender did not contribute to heterogeneity within subgroups. A sensi-
tivity analysis, excluding one study at the time, neither reduced heterogeneity nor affected the
overall estimates to a noticeable extent (S1 and S2 Tables). Visual inspection of the funnel plot
(S5 Fig), and regression tests of funnel plot asymmetry (p = 0.31 and p = 0.72 for SBP and
Fig 1. Flow chart of the selection process. Flow chart of the selection process according to the PRISMA Statement [24].
doi:10.1371/journal.pone.0147601.g001
Ethnicity and Blood Pressure in Europe
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Table 1. Characteristics of studies included in analysis.
Author [Ref] Study
Design
Time of
study
Sampling
frame
Country Study
populations
(n =)
Indicator of
panethnicity
Age
range
(years)
Method of BP
measurement
(device)
RR (%) Gender Quality
score
Meade et al.[39] PS 1977 FB UK EU(412), SSA(141) CB 18–49 Not given NR M/W 7
Sever et al.[40] CSS 1978 FB UK EU(62), SSA(53) NR 24–58 A(Bosomat) 55 M/W 7
Haines et al.[30] CSS 1983–1986 GPL UK EU(936), SSA(415) CB 17–70 RZ 61 M/W 10
McKeigue et al.
[46]
CSS 1985–1986 GPL UK EU(132), SA(121) SR 35–69 RZ 81 M/W 10
Cruickshank et al.
[31]
CSS NR GPL UK EU(101),SSA(106),
SA(107)
SR 45–74 RZ 77 M/W 8
McKeigue et al.
[36]
CSS 1988–1990 FB, GPL UK EU(1761),SSA
(209),SA(1712)
N,CB 45–74 RZ 66 EU; 62
SA; 66
SSA
M/W 10
Knight et al.[47] CSS 1989 FB UK EU(156), SA(96) N,SR 20–65 A(Copal) 71 EU; 83
SSA
M 10
Chaturvedi et al.
[32]
CSS NR GPL UK EU(585), SSA(581) SR 40–69 RZ 58 M/W 10
Knight et al.[48] CSS NR FB UK EU(160), SA(128) N,SR 20–65 A(Copal) 71 EU; 83
SSA
M 10
Simmons et al.
[52]
CSS 1986–1989 PL UK EU(5508), SA(4395) CB >20 RZ NR M/W 10
Cappuccio et al.
[33]
CSS 1994–1996 GPL UK EU(524),SSA(549),
SA(505)
SR 40–59 A
(Arteriosonde)
64 M/W 10
Bhopal et al.[49] CSS 1993/94 EU;
1995/97 SA
GPL UK EU(825), SA(684) CB 25–74 Manual 64 EU; 67
SA
M/W 10
HSE 1999 [43] CSS 1999 - UK EU(11884),SSA
(719),SA(1973)
CB >16 - NR M/W 10
Whitty et al.[41] CS 1985–1988 OS UK EU(8973), SSA
(360), SA(577)
SR 35–56 RZ 73 M/W 10
Lane et al.[34] CS 1979/86 and
1996/97
FB UK EU(2067), SSA
(394), SA(226)
SR 30–60 RZ NR M/W 9
HSE 2004. [47] CSS 2004 - UK EU(9183), SSA
(675), SA(1197)
CB >16 - NR M/W 10
Agyemang et al.
[42]
CSS 2001–2003 PL NL EU(508), SSA(581),
SA(294)
SR 35–60 A(Omron M-4) 61 M/W 10
Lyratzopoulos
et al.[50]
CSS 1989–1999 PL UK EU(9995), SA(9990) N 35–60 Manual NR M/W 9
Glenday et al.
[53,54]
CSS 2002 PL NO EU(11027), SA
(1976)
CB 31–60 A(DINAMAP) 40 M/W 10
Gualdi-Russo
et al.[38]
CSS 2000–2002 IC I EU(104), SSA(44),
SA(78)
CB 17–65 Manual 67 M 7
Gray et al.[51] CSS 2004–2007 GPL UK EU(4688), SA(1353) SR 40–75 A(Omron) 22 M/W 9
Rabanal et al.
[58]
CSS 1994–2003 PL NO EU(58698), SSA
(183), SA(1071)
CB 40–65 - 58 M/W 10
Agyemang et al.
[59]
PS 2011 PL NL EU(2097), SSA
(4060), SA(2278)
CB 18–70 A(Microlife) 63 M/W 10
BP = Blood Pressure; RR = Response Rate; PS = prospective study; CSS = Cross Sectional Survey; CS = Cohort Study; FB = Factory based;
GPL = General practices list; HC = Health centre; PL = Population List; OS = Office staff; IC = Immigrant centres; UK = United Kingdom; NL = The
Netherlands; NO = Norway; I = Italy; EU = Europeans; SSA = Sub-Saharan Africans (including populations also defined as Africans, Afro-Caribbeans, and
Black Caribbeans); SA = South Asians; CB = Country of birth; NR = Not Reported; N = Name; SR = Self-reported; RZ = random zero manometer;
A = automated sphygmomanometer; M = men; W = Women.
doi:10.1371/journal.pone.0147601.t001
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DBP, respectively) showed no formal evidence of publication bias. Application of trim and fill
to the SBP and DBP meta-analysis did not reveal missing studies.
Visual inspection of the funnel plot (S5 Fig), and regression tests of funnel plot asymmetry
(p = 0.31 and p = 0.72 for SBP and DBP, respectively) showed no formal evidence of publica-
tion bias. Application of trim and fill to the SBP and DBP meta-analysis did not reveal missing
studies.
To further investigate sources of heterogeneity among studies on SA participants, studies
were grouped according to the country of origin. The Q-statistic for subgroups differences was
highly significant for SBP and DBP in both genders (p<0.001 for all). Interestingly, BP differ-
ences were larger in subjects coming from Bangladesh and Pakistan for both SBP (S6 Fig) and
DBP (S7 Fig). When studies were grouped according to the dominant religion in the country of
origin, participants from Muslim countries showed significantly lower BP values than EU for
both SBP (-9.22 mmHg 95% CI -11.44 to -7.00 in men, and -8.47 mmHg, 95% CI -10.75 to
-6.18 in women) and DBP (-3.23, 95% CI -5.24 to -1.23 in men, and -1.57, 95% CI -2.28 to
-0.85 in women). Differences between Muslim and non-Muslim participants were significant
Table 2. Age, mean prevalence of diabetes mellitus, bodymass index, and smoking habit by gender among Sub-Saharan Africans and native
Europeans.
Author [Ref] Age
(range)
MEN WOMEN
Age
(mean)
Diabetes (%) BMI
(kg/m2)
Smokers
(%)
Age
(mean)
Diabetes (%) BMI
(kg/m2)
Smokers
(%)
SSA EU SSA EU SSA EU SSA EU SSA EU SSA EU SSA EU SSA EU
Meade et al.[42] 18–49 35.5 34.7 - - 24.5 24.4 47.9 47.9 38.6 36.9 - - 27.4 23.6 7.3 59.0
Sever et al.[43] 24–58 42.0 42.0 - - - - - - 44.0 43.0 - - - - -
Haines et al.[33] 17–70 41.4 42.4 - - 25.0 25.3 41.4 46.3 36.5 40.9 25.8 25.2 27.5 45.6
Cruickshank et al.
[34]
45–74 57.0 62.2 41.0* 4.0* 26.0 26.2 - - 56.6 60.3 13.0* 2.0* 29.1 26.3 -
McKeigue et al.[39] 40–69 - - 14.6* 4.8* 26.3 25.9 - - - - - - - - -
Chaturvedi et al.[35] 40–64 55.0 55.0 12.9* 6.5* 26.0 26.4 30.0 37.0 55.0 55.0 17.7* 4.0* 29.1 26.0 8.0 35.0
Cappuccio et al.[36] 40–59 51.1 49.8 18.0* 7.0* 26.4 25.8 18.6 39.6 51.1 49.8 15.0* 5.0* 29.3 26.1 9.2 33.3
Whitty et al.[44] 35–56 45.8 43.8 5.0* 2.0* - - 17.0 15.0 45.8 43.8 5.0* 2.0* - - 9.0 26.0
HSE 1999 [46] >16 43.1 45.0 7.8 3.3 27.1 26.6 35.0 27.0 41.3 45.4 7.9 2.5 28.0 26.4 25.0 27.0
Lane et al.[37] >30 44.6 44.1 - - 26.2 25.9 50.0 40.6 45.0 43.9 - - 28.7 25.6 10.9 49.2
HSE 2004 (BC) [47] >16 45.2 47.4 10.0** 4.3** 27.1 27.1 25.0 24.0 43.3 47.2 8.4** 3.4** 28.0 26.8 24.0 23.0
HSE 2004 (BA) [47] >16 45.2 47.4 5.0** 4.3** 26.4 27.1 21.0 24.0 36.4 47.2 2.1** 3.4** 28.8 26.8 10.0 23.0
Agyemang et al.[45] 35–60 44.1 48.1 11.9 7.8 26.4 26.2 55.5 54.0 43.4 47.4 12.8 5.8 29.4 26.1 - -
Gualdi-Russo et al.
[41]
17–65 34.7 37.0 - - 22.9 25.2 - - - - - - - - - -
Rabanal et al.[58] 40–65 42.5 48.6 5.0 3.0 25.7 26.9 32.0 39.0 46.7 48.7 5.0 2.0 28.6 25.9 32.0 45.0
Agyemang et al.
(AS)[59]
18–70 47.6 47.3 - - 26.4 25.2 42.6 27.0 47.5 45.5 - - 28.8 24.3 23.9 24.2
Agyemang et al.(G)
[59]
18–70 47.1 47.3 - - 26.8 25.2 7.8 27.0 43.9 45.5 - - 29.5 24.3 2.4 24.2
BMI = body mass index; SSA = Sub-Saharan Africans; EU = Europeans; BC = Black Caribbeans; BA = Black Africans; AS = African Surinamese; G = G =
Ghanians.
* = Oral Glucose Tolerance Test (75 g);
** = Self-reported doctor-diagnosed diabetes.
doi:10.1371/journal.pone.0147601.t002
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Table 3. Age, mean prevalence of diabetes mellitus, bodymass index, and smoking habit by gender among South Asians and native Europeans.
Author [Ref] Age
(range)
MEN WOMEN
Age
(mean)
Diabetes (%) BMI
(kg/m2)
Smokers
(%)
Age
(mean)
Diabetes (%) BMI
(kg/m2)
Smokers
(%)
SA EU SA EU SA EU SA EU SA EU SA EU SA EU SA EU
McKeigue et al.[46] 35–69 50.7 50.9 22.0* 10.0* 23.9 26.6 82.0 45.0 49.7 51.4 23.0* 4.0* 23.7 26.1 22.0 39.0
Cruickshank et al.
[31]
45–74 62.2 62.2 31.0* 4.0* 25.2 26.2 - - 60.0 60.3 28.0* 2.0* 26.8 26.3 - -
McKeigue et al.[36] 40–69 - - 19.6* 4.8* 25.7 25.9 - - - - 16.1* 2.3* 27.0 25.2 - -
Knight et al.[47] 20–65 39.3 41.0 12.7* 4.5* 23.8 25.2 43.8 43.9 - - - - - - - -
Knight et al.[48] 20–65 41.0 41.0 10.9* 4.4* 24.5 25.0 39.1 43.8 - - - - - - - -
Simmons et al.[52] 20–60 - - 12.4* 3.2* - - 24.0 48.0 - - 11.2* 4.7* - - 3.0 47.0
Cappuccio et al.[33] 40–59 49.4 49.8 25.0* 7.0* 24.8 25.8 25.2 39.6 49.4 49.8 20.0* 5.0* 27.1 26.1 2.9 33.3
Bhopal et al.
(Indians) [49]
25–74 50.7 54.2 16.0* 16.0* 26.9 26.1 14.0 32.0 52.4 54.0 20.0* 15.0* 27.9 26.0 1.0 31.0
Bhopal et al.
(Pakistanis) [49]
25–74 52.2 54.2 35.0* 16.0* 26.6 26.1 32.0 32.0 48.3 54.0 34.0* 15.0* 27.8 27.0 5.0 31.0
Bhopal et al.
(Bangladeshi)[49]
25–74 47.7 54.2 17.0* 16.0* 25.4 26.1 57.0 32.0 48.1 54.0 13.0* 15.0* 26.3 28.0 2.0 31.0
HSE 1999(Indians)
[43]
>16 41.2 45.0 7.7** 3.3** 25.2 26.6 23.0 27.0 40.3 45.4 4.7** 2.5** 25.9 26.4 6.0 27.0
HSE 1999
(Pakistanis)[43]
>16 37.6 45.0 8.7** 3.3** 25.4 26.6 26.0 27.0 34.6 45.4 5.3** 2.5** 26.5 26.4 5.0 27.0
HSE 1999
(Bangladeshi)[43]
>16 39.2 45.0 10.6** 3.3** 23.8 26.6 44.0 27.0 33.9 45.4 5.9** 2.5** 24.1 26.4 1.0 27.0
Whitty et al.[41] 35–56 46.3 43.8 7.0* 2.0* - - 25.0 15.0 46.3 43.8 7.0* 2.0* - - 6.0 26.0
Lane et al. [34] >30 44.5 44.1 - - 25.2 25.9 31.3 40.6 - - - - - - - -
HSE 2004 (Indians)
[44]
>16 43.5 47.4 10.1** 4.3** 25.8 27.1 20.0 24.0 41.9 47.2 5.9** 3.4** 26.2 26.8 5.0 23.0
HSE 2004
(Pakistanis) [44]
>16 37.9 47.4 7.3** 4.3** 25.9 27.1 29.0 24.0 35.0 47.2 8.6** 3.4** 27.1 26.8 5.0 23.0
HSE 2004
(Bangladeshi) [44]
>16 38.8 47.4 8.2** 4.3** 23.8 27.1 40.0 24.0 35.0 47.2 5.2** 3.4** 25.7 26.8 2.0 23.0
Agyemang et al.[42] 35–60 44.3 48.1 24.8 7.8 26.4 26.2 48.5 54.0 45.0 47.4 25.8 5.8 27.5 26.1 - -
Lyratzopoulos et al.
[50]
35–60 44.2 45.6 - - 25.9 26.7 27.4 43.6 43.7 45.7 - - 26.4 26.0 7.0 34.4
Glenday et al.
(Pakistanis)[53,54]
31–60 45.3 44.6 11.0* 2.0* 27.4 26.3 37.0 27.0 43.9 44.3 14.0* 1.0* 29.3 24.8 5.0 27.0
Glenday et al.(Sri
Lankans)[53,54]
31–60 40.1 44.6 8.0* 2.0* 25.7 26.3 19.0 27.0 39.5 44.3 10.0* 1.0* 26.8 24.8 19.0 27.0
Gualdi-Russo et al.
[38]
17–65 32.6 37.0 - - 22.8 25.2 - - - - - - - - - -
Gray et al.[51] 40–75 53.9 58.7 6.1* 3.4* 26.6 28.2 - - 52.2 58.5 4.1* 2.2* 28.4 28.4 - -
Rabanal et al.[58] 40–65 46.7 48.6 14.0 3.0 26.8 26.9 28.0 39.0 46.7 48.4 15.0 2.0 29.0 25.9 2.0 45.0
Agyemang et al.[59] 18–70 45.2 47.3 - - 25.7 25.2 39.5 27.0 46.7 45.5 - - 26.9 24.3 18.6 24.2
BMI = body mass index; SA = South Asians; EU = Europeans.
* = Oral Glucose Tolerance Test (75 g);
** = Self-reported doctor-diagnosed diabetes.
doi:10.1371/journal.pone.0147601.t003
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(Fig 4) for both SBP and DBP (p<0.001 for all comparisons) regardless of gender (interaction
p = 0.644 and p = 0.126 for SBP and DBP respectively).
Role of potential effect modifiers
Because heterogeneity among studies and subgroups was substantial (I-squared> 85%), we
used multivariate random-effect meta-regression to investigate the role of potential effect mod-
ifiers of BP differences (panethnicity, gender, study year, and the differences in diabetes preva-
lence, BMI, age at examination, and smoking prevalence between minority groups and EU).
Panethnicity had a highly significant effect on both SBP (Table 4) and DBP mean differences
(Table 5). In both models, gender and the interaction terms were not significant. We also tested
study quality as a potential effect modifier in a meta-regression model (S3 Table) and found no
evidence of a significant effect for both SBP and DBP.
In further multivariate meta-regression analyses (including all candidate effect modifiers),
the weighted mean SBP difference between minority groups and EU, was largely influenced by
panethnicity and by the difference in diabetes prevalence (Table 6) while study year, difference
in BMI, age at examination, and the difference in smoking prevalence did not reach formal sta-
tistical significance. The proportion of residual between-study variance (final model τ2 = 8.37
Fig 2. SBP differences betweenminority groups and EU participants by panethnicity and gender. Subgroup comparisons of the weighted mean
difference of systolic blood pressure (BP) between minority groups and EU participants by panethnicity and gender. Diamonds denote the pooled estimates
and 95% confidence intervals. SSA = Sub-Saharan Africans; SA = South Asians; EU = Europeans, “n” is the number of comparisons available for each
subgroup.
doi:10.1371/journal.pone.0147601.g002
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and model without covariates τ2 = 39.35) explained by including the above covariates in the
model was large (Adjusted R-squared 78.73%), but still significantly different from zero(likeli-
hood ratio test of τ2 = 0, p<0.001).
Representative plots of the joint effect of panethnicity and difference in diabetes prevalence
on the weighted mean SBP difference for women and men are shown in Fig 5.
For DBP the weighted mean difference was influenced only by panethnicity (4.24 mmHg,
95% CI 1.77 to 6.71, p = 0.001) whereas none of the other tested effect modifiers had a signifi-
cant effect.
Discussion
The results of this systematic review and meta-analysis show that: a) SSA living in Europe have
higher BP levels than EU; in the highly heterogeneous group of SA, BP levels are on average
lower than in EU, mainly owing to the finding of lower BP values in people coming fromMus-
lim countries; b) in meta-regression analyses the weighted mean SBP difference between
minority groups and EU, was not influenced by the year of the survey; c) the presence of diabe-
tes, irrespective of origin, is associated with higher BP levels.
Fig 3. DBP differences betweenminority groups and EU participants by panethnicity and gender. Subgroup comparisons of the weighted mean
difference of diastolic blood pressure (BP) between minority groups and EU participants by panethnicity and gender. Diamonds denote the pooled estimates
and 95% confidence intervals. SSA = Sub-Saharan Africans; SA = South Asians; EU = Europeans, “n” is the number of comparisons available for each
subgroup.
doi:10.1371/journal.pone.0147601.g003
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These results lead to three important considerations: a) prevention strategies implemented
in Europe played a key role in reducing BP in general population and in reducing the incidence
of CV disease in Europe; however, the difference of BP levels between SSA and EU was consis-
tent over years thus suggesting the importance of population specific intervention strategies; b)
Fig 4. BP differences between subjects originating from SA countries and EU participants by dominant religion in the country of origin. Subgroup
comparisons of the weighted mean difference of systolic and diastolic blood pressure between South Asians (SA) and European (EU) participants by
dominant religion in the country of origin. The term "others" refers to comparisons performed between EU participants and subjects who originated from
countries with a different dominant religion. Diamonds denote the pooled estimates and 95% confidence intervals, “n” is the number of comparisons available
for each subgroup.
doi:10.1371/journal.pone.0147601.g004
Table 4. Random effect meta-regression estimates of systolic blood pressure for panethnicity, gender and their interaction.
Variables Point Estimate 95% CIs p-value Multiplicity adjusted p-value
Panethnicity (SSA vs. SA) 8.014 4.369 to 11.660 <0.001 <0.001
Gender (Women vs. Men) 1.618 -1.762 to 4.998 0.348 0.650
Interaction Term
Panethnicity x Gender 0.860 -4.529 to 6.249 0.755 0.980
SSA = Sub-Saharan Africans; SA = South Asians; EU = Europeans. Systolic blood pressure Model (number of comparisons = 80): Intercept: -4.5857
mmHg (-6.862 to -2.310; p<0.001); Proportion of between-study variance explained (Adjusted R-squared) = 34.45%; Joint test for all covariates F = 13.34,
p<0.0001
doi:10.1371/journal.pone.0147601.t004
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the finding of lower BP levels in SA Muslim populations suggests the importance of as yet
untapped lifestyle and behavioral habits of such populations (religion being a likely proxy for
them) that may represent an advantage reflecting a lower predisposition towards the develop-
ment of hypertension; c) the additive effect of diabetes, independent from origin, in explaining
the findings of elevated BP levels emphasizes the need to develop new strategies for the preven-
tion and control of hypertension and ensuing CV disease in groups at higher prevalence of
diabetes.
Sub Saharan Africans
SSA individuals living in Europe have higher BP values than EU independently of gender. Con-
sistent with raised BP levels, an excess risk of stroke and renal disease was observed for SSA liv-
ing in Europe [5,6]. The term SSA was adopted to accommodate the population divisions used
in the papers analysed although it is to be acknowledged the heterogeneity of this SSA group in
terms of language, diet, and religious practices [2,60]. Whilst there may be genetic markers of
predisposition to hypertension in SSA populations [2,61,62] it is clear from international and
migration studies that their higher burden of hypertension is highly modifiable with lifestyle
changes and adaptations to host environments [2,63,64]. This consideration encouraged public
and health care systems to intervene in this group. Awareness of the higher burden of hyper-
tension in SSA subjects was reported to be high amongst European physicians who more cor-
rectly recognize and diagnose hypertension in SSA than in other ethnic groups [36]. Likewise
specific prevention strategies for hypertension in SSA (mainly low sodium diet) exist [65]. In
Table 5. Random effect meta-regression estimates of diastolic blood pressure for panethnicity, gender and their interaction.
Variables Point Estimate 95% CIs p-value Multiplicity adjusted p-value
Panethnicity (SSA vs. SA) 3.896 1.757 to 6.035 <0.001 <0.001
Gender (Women vs. Men) 0.366 -1.587 to 2.318 0.713 0.980
Interaction Term
Panethnicity x Gender 1.593 -1.569 to 4.755 0.323 0.700
SSA = Sub-Saharan Africans; SA = South Asians; EU = Europeans. Diastolic blood pressure Model (number of comparisons = 76): Intercept: -0.598
mmHg (-1.912 to 0.716); p = 0.373); Proportion of between-study variance explained (Adjusted R-squared) = 33.02%; Joint test for all covariates
F = 11.91, p<0.0001
doi:10.1371/journal.pone.0147601.t005
Table 6. Weightedmean difference in systolic blood pressure in relation to explanatory variables in multivariate meta-regressionmodel including
all potential effect modifiers.
Variables Point Estimate 95% CIs p-value Multiplicity Adjusted p-value
Panethnicity (SSA vs. SA) 7.674 4.757 to 10.591 <0.001 <0.001
Diabetes Prevalence (1% difference) 0.315 0.129 to 0.501 0.001 0.004
Study Year (1 year) 0.114 -0.189 to 0.417 0.460 0.990
Body Mass Index (1 kg/m2 difference) 0.165 -0.868 to 1.198 0.755 1.000
Age at examination (1 year difference) 0.547 0.058 to 1.037 0.028 0.120
Gender (Women vs. Men) -3.101 -6.699 to 0.496 0.091 0.380
Smoking Prevalence (1% difference) -0.194 -0.397 to 0.009 0.062 0.280
Differences were calculated by subtracting the average values of Minority groups from those of Europeans. SSA = Sub-Saharan Africans; SA = South
Asians; EU = Europeans. Model for Systolic blood pressure (number of comparisons = 42): Proportion of between-study variance explained (Adjusted R-
squared) = 78.73%; joint test for all covariates F = 14.33, p<0.0001
doi:10.1371/journal.pone.0147601.t006
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addition, minority SSA (or SA) groups at the end of the 1970s were likely to be different from
their counterparts at the end of the 2000s in terms of immigration reasons, habits, and socio-
economic status. All these factors could eventually influence the risk of high BP. The studies
included in this meta-analysis were carried out in Europe over a period of over 30 years (from
1977 to 2015), and may give us the opportunity to assess whether BP differences in the SSA
group were influenced by time. However, when the potential interaction between time trends
for differences in BP and other CV risk factors, body mass index and diabetes was taken into
account, the heterogeneity of the studies was not influenced by the time of data collection.
Therefore limitations of prevention strategies so far implemented in effectively reaching
minority subgroups and in modifying their CV risk profile are evident.
South Asians
BP levels are not significantly higher in SA than in EU. This finding apparently does not fit
with the higher incidence of stroke and CV death in SA living in Europe as compared with EU
Fig 5. Gender specific meta-regression model. Women (number of comparisons = 28). Intercept: -8.260 mmHg (-12.167 to -4.352; p<0.001); Ethnicity:
8.695 mmHg (3.751 to 13.640; p = 0.001); Difference in Diabetes Prevalence: 0.543 mmHg (0.207 to 0.880; p = 0.002). Proportion of between-study variance
explained (Adjusted R-squared) = 45.81%; joint test for all covariates F = 9.79, p<0.0017.Men (number of comparisons = 31). Intercept: -7.730 mmHg
(-10.268 to -5.193; p<0.001); Ethnicity: 8.496 mmHg (5.234 to 11.759); p<0.001); Difference in Diabetes Prevalence: 0.481 mmHg (0.162 to 0.600; p<0.001).
Proportion of between-study variance explained (Adjusted R-squared) = 60.73%; joint test for all covariates F = 18.04, p<0.001.
doi:10.1371/journal.pone.0147601.g005
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[5,8,66,67]. The heterogeneity of studies carried out in SA is however large. Beside the high
prevalence of diabetes mellitus, uniformly higher in SA than in many other populations,
genetic predisposition may also contribute to the high CV disease burden in SA [68,69]. The
so-called SA group is highly heterogeneous also because SA living in Europe cover a wide
range of migrant profiles (professionals, business elites, unskilled labourers, refugees). In addi-
tion, SA ethnic roots originate from the Indian subcontinent, a large geographic area that
includes India, Pakistan, Sri Lanka, Nepal, and Bangladesh, with important differences in diet,
culture, and lifestyle among different populations and religions. BP variations between SA pop-
ulations in Europe with different countries of origin have already been reported [52] and
important differences between Hindus and Muslims have been found [63,70]. In the present
analysis, when study populations are categorized according to the main religion of the country
of origin, this factor also significantly contributes to the heterogeneity. The country of origin
and religion are proxies for other risk factors and behaviours (i.e. alcohol use, vegetarian diet,
use of different cooking procedures) [71] that may explain some of the differences. Unfortu-
nately, data on alcohol consumption, and diet are not available in most of included cohorts. In
addition, the classification of studies including mixed populations as 'other' [53], might lead to
a misrepresentation. The use of the main religion in the country of origin as a proxy for religion
of the migrant populations, might also lead to a biased sample, with the clearest example being
minority populations fleeing persecution from majority populations. However, notwithstand-
ing the presence of Muslim subjects among populations classified as 'other' and the presence of
non-Muslim individuals within the Muslim group, differences are evident. It might thus be
important to consider this aspect in culturally-specific strategies for prevention [72].
Lifestyle modification can also slow down the progression of diabetes mellitus. Although
mean BMI seems comparable between SA and EU, it should be considered that compared with
EU, SA subjects have increased abdominal visceral fat and greater insulin resistance at similar
levels of BMI [73]. It has indeed been argued that at comparable values of BMI, SA subjects
may have a higher risk of CV disease than EU [3,39,74,75]. Data on waist circumference are
not available in most of included cohorts. In spite of this, and although the measurement of
BMI might not be a key factor to explain the observed heterogeneity [76], it is essential to
encourage the control of body weight in migrant populations because of its relationship with
diabetes.
Strengths and limitations
This meta-analysis has some strengths: the overall large size enabling subgroup analyses, and
the common study strategies. The study includes cohorts from all over Europe, although the
data are predominantly UK-based.
Because of the nature of the studies and the large statistical heterogeneity, this systematic
review has some limitations. When working with observational studies there is a good chance
that heterogeneity exists between studies and that heterogeneity can be more extreme in obser-
vational studies than interventional studies [77]. Indeed, large heterogeneity can be problem-
atic if a single summary measure is used[78], therefore we stratified by study level features and
used regression analysis to quantitatively assess the extent to which pooled estimates varied
along with these features[77–79]. We believe that our careful and comprehensive approach
reduces the impact of heterogeneity on estimates and can make an important contribution to
debates on public health policy.
Despite adjustment for known potential confounders, we cannot rule out the possibility that
the observed associations are confounded by other unmeasured factors such as dietary sodium
and potassium. This problem is made more complex by scenarios that include possible
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differences in the use of antihypertensive treatment among subgroups. In the Health Survey for
England (HSE) study [46], treatment rates were found to be highest among black men and
women. Among those on antihypertensive medication, the odds of having BP controlled
(SBP<160 mm Hg and DBP<95 mm Hg) did not differ among the three groups of older men
but was reduced in older SA women, compared with white women.
Average BP values measured at the population level may be influenced by both the number
of measurements performed at a single visit, and by the number of visits considered by the
study protocol. Although these methodological aspects may sometimes limit the possibility to
compare absolute results obtained in different studies, they unlikely influenced the interpret-
ability of our results, the same methodology being adopted for the different ethnic groups
within the same study. The same consideration is also valid for diabetes, the same diagnostic
criteria being adopted for different groups within the same study.
Finally, the pragmatic approach we adopted to accommodate studied populations in two
large panethnic groups, limits the possibility to investigate in details the role of ethnicity. The
essence of ethnicity embodies shared origins or social background, culture, language and reli-
gious traditions that are distinctive, maintained between generations, which lead to a sense of
identity, and group.
SSA and SA groups are highly heterogeneous so that future research should prioritize the
examination of variation within the two groups.
Conclusions
The control of hypertension among minority groups is crucial for addressing social inequalities
in health care. To avoid escalation of such inequalities, two main strategies might be consid-
ered. From the point of health care delivery, easier access to services as well as availability and
affordability of antihypertensive drugs should be facilitated and awareness of specific needs
among practitioners should be improved. However these interventions might be still ineffective
in transferring the concept of prevention to migrant and vulnerable populations. Public health
preventive strategies should match health care provision. It has taken decades to educate and
increase awareness amongst EU citizens on the importance of prevention but only few Euro-
pean Union member states so far offer all undocumented migrants the opportunity to have
their BP treated [1,9,14]. Ignoring this when immigration is increasing might halt the virtuous
reduction of CV events that has occurred in Europe over the last decades.
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